Authors:
Chang, J
Powles, TJ
Allred, DC
Ashley, SE
Makris, A
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients, CLIN CANC R, 6(2), 2000, pp. 616-621
Authors:
Chang, J
Ormerod, M
Powles, TJ
Allred, DC
Ashley, SE
Dowsett, M
Citation: J. Chang et al., Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma, CANCER, 89(11), 2000, pp. 2145-2152
Authors:
Makris, A
Powles, TJ
Allred, DC
Ashley, SE
Trott, PA
Ormerod, MG
Titley, JC
Dowsett, M
Citation: A. Makris et al., Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study, BREAST CANC, 53(1), 1999, pp. 51-59
Authors:
Makris, A
Powles, TJ
Kakolyris, S
Dowsett, M
Ashley, SE
Harris, AL
Citation: A. Makris et al., Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma, CANCER, 85(9), 1999, pp. 1996-2000
Authors:
Makris, A
Powles, TJ
Ashley, SE
Chang, J
Hickish, T
Tidy, VA
Nash, AG
Ford, HT
Citation: A. Makris et al., A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer, ANN ONCOL, 9(11), 1998, pp. 1179-1184